Preclinical and Clinical Studies of MMP Inhibitors in Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
1997 • 3,094 citations
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
1997 • 1,608 citations
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
1993 • 1,523 citations
Processing of tumour necrosis factor-α precursor by metalloproteinases
1994 • 1,200 citations
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
1988 • 1,050 citations
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
1994 • 769 citations
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
1996 • 449 citations
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
1990 • 406 citations
Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors
1996 • 404 citations
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
1996 • 312 citations
Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins
1991 • 287 citations
Recent advances in matrix metalloproteinase inhibitor research
1996 • 279 citations
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
1994 • 217 citations
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
1998 • 211 citations
Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis.
1986 • 125 citations
Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers
1998 • 104 citations
Matrix metalloproteinase inhibitors in the treatment of cancer
1997 • 88 citations
Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors
1990 • 80 citations
Relaxed Specificity of Matrix Metalloproteinases (MMPS) and TIMP Insensitivity of Tumor Necrosis Factor-α (TNF-α) Production Suggest the Major TNF-α Converting Enzyme Is Not an MMP
1996 • 69 citations
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.
1997 • 61 citations
Batimastat
1996 • 16 citations
Recent advances in matrix metalloproteinase inhibitor research and development.
1998 • 12 citations
Expression of matrix metalloproteinases in colorectal cancer
1996 • 2 citations